Tomomi Okubo
Kagawa Prefectural Central Hospital(JP)Nippon Medical School Hospital(JP)Chiba Hokusou Hospital(JP)Nippon Medical School(JP)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Pancreatic and Hepatic Oncology Research, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis(2022)128 cited
- → Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population(2022)126 cited
- → Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study(2022)77 cited
- → Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice(2022)77 cited
- → Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience(2021)76 cited
- →